在法国公务员中针对2型糖尿病进行基于工作场所的葡萄糖查:前性观察队列研究
Solène Petit1, Florence Carrouel2, Benjamin du Sartz de Vigneulles2
1Institute of Public Health, Epidemiology and Development (ISPED), Inserm U1219, University of Bordeaux, Bordeaux, France.
JMIR public health and surveillance
|December 22, 2025
概括
工作场所的葡萄糖查在法国公务员中发现了新的2型糖尿病病例. 这种系统的方法有助于在服务不足的人群中早期发现和预防T2D并发症.
科学领域:
- 公共卫生 公共卫生
- 预防医学 预防医学
- 内分泌学 在内分泌学.
背景情况:
- 2型糖尿病 (T2D) 是一个全球性的健康挑战,到2024年将影响5.89亿成年人,超过90%的人患有T2D.
- 在法国,有410万成年人患有糖尿病,近25%仍未被诊断出来,这凸显了早期检测的必要性.
- 工作场所查计划提供了一种可行的策略,可以帮助那些无法获得常规医疗保健的有工作的成年人.
研究的目的:
- 评估法国公务员系统糖尿病查计划的有效性.
- 为了确定新发现的糖尿病病例的比率.
- 在这个人群中描述相关心脏代谢风险因素.
主要方法:
- 一项回顾性观察性研究分析了葡萄糖查计划 (2022年1月至2025年2月) 的数据.
- 餐后血糖>1.40 g/L的参与者被纳入后续队列.
- 收集和分析了社会人口统计,临床和生物数据.
主要成果:
- 在16,785名查者中,134人有资格接受随访;70人完成了随访.
- 在9人 (12.9%的跟踪者) 中确诊了T2D.
- 新诊断的T2D病例更有可能是男性和超重/肥胖.
结论:
- 在职业环境中进行系统的葡萄糖查有效地识别出患糖尿病或糖尿病前期风险的个体.
- 将其纳入预防性健康策略可以提高早期检测并减少长期并发症.
- 需要进一步的前性研究来确认长期益处.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Oral Hypoglycemic Agents: Biguanides and Glitazones
559
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
559
Hormones Regulating Blood Glucose
6.3K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.3K
Carbohydrate Metabolism
13.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.7K
Oral Hypoglycemic Agents: Glinides
560
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
560


